FDF Scotland Launches New Funding to Help SMEs Ahead of HFSS Deadline

Why It Matters

The funding enables SMEs to safeguard shelf‑space and promotional rights while aligning products with stricter public‑health standards, reducing the risk of lost sales under the upcoming HFSS rules.

Key Takeaways

• Up to £5,000 ($6,250) grants for product reformulation
• Funding covers trial ingredients, analysis, software, consultancy
• Open to all Scottish food & drink SMEs, even non‑HFSS
• Applications close 31 May 2026, six months before regulations start

Pulse Analysis

Scotland’s Food and Drink Federation (FDF) is stepping in as the UK’s high‑fat, sugar and salt (HFSS) rules loom, targeting a 1 October 2026 rollout that will bar certain products from prime in‑store placements. By applying the UK Nutritional Profile Model, the legislation will restrict end‑of‑aisle displays, seasonal promotions and multi‑buy offers for items deemed unhealthy, a move that could shrink visibility for many small‑scale producers. For SMEs that rely on impulse buying and festive campaigns, the regulatory shift represents a potential revenue cliff unless they adapt quickly.

To mitigate that risk, FDF Scotland’s new funding scheme offers up to £5,000 per company—roughly $6,250—to offset reformulation costs. The grant can be spent on trial ingredients, laboratory‑grade nutritional analysis, recipe‑development software and specialist consultancy, all complemented by confidential guidance on calculating pre‑ and post‑reformulation NPM scores. By lowering financial barriers, the programme encourages manufacturers to lower fat, sugar or salt levels, thereby preserving shelf‑space and promotional eligibility while delivering healthier options to consumers.

Beyond immediate compliance, the initiative signals a broader industry pivot toward nutrition‑focused innovation. Companies that successfully reformulate can differentiate themselves in a market increasingly driven by health‑conscious shoppers and retailers tightening placement criteria. Moreover, the programme may set a precedent for other UK regions to adopt similar support mechanisms, fostering a more resilient SME ecosystem that balances public‑health objectives with commercial viability.